Digital pathology and artificial intelligence will be key to supporting clinical and academic cellular pathology through COVID-19 and future crises: the PathLAKE consortium perspective.

Journal: Journal of clinical pathology
Published Date: Jul 3, 2020

Abstract

The measures to control the COVID-19 outbreak will likely remain a feature of our working lives until a suitable vaccine or treatment is found. The pandemic has had a substantial impact on clinical services, including cancer pathways. Pathologists are working remotely in many circumstances to protect themselves, colleagues, family members and the delivery of clinical services. The effects of COVID-19 on research and clinical trials have also been significant with changes to protocols, suspensions of studies and redeployment of resources to COVID-19. In this article, we explore the specific impact of COVID-19 on clinical and academic pathology and explore how digital pathology and artificial intelligence can play a key role to safeguarding clinical services and pathology-based research in the current climate and in the future.

Authors

  • Lisa Browning
    Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Richard Colling
    Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Emad Rakha
    School of Medicine, University of Nottingham, Nottingham, Nottinghamshire, UK.
  • Nasir Rajpoot
    Department of Computer Science, University of Warwick, Coventry, UK.
  • Jens Rittscher
    Department of Engineering Science, University of Oxford, Oxford, United Kingdom.
  • Jacqueline A James
    Precision Medicine Centre of Excellence, Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Belfast, UK.
  • Manuel Salto-Tellez
    Integrated Pathology Unit, Division of Molecular Pathology, The Institute of Cancer Research London and The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
  • David R J Snead
  • Clare Verrill
    Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK; Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK. Electronic address: Clare.Verrill@ouh.nhs.uk.

Keywords

External Resources

Popular Topics
Recent Journals